FDA Drug recall D-1039-2016
tabcin ACTIVE M.R. Capsules, 12-count box , UPC 7501008485057
- FDA Drug
- Class II
- terminated
- Published 2016-06-29
On 2016-06-29 the FDA classified a Class II recall of tabcin ACTIVE M.R. Capsules, 12-count box , UPC 7501008485057 by Profarma Distributors, citing CGMP Deviations.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1039-2016 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-05-11 |
| Published | 2016-06-29 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Profarma Distributors |
| Distribution | US |
Product
tabcin ACTIVE M.R. Capsules, 12-count box , UPC 7501008485057
Reason
CGMP Deviations
Identifiers
| upc | 7501008485057 |
|---|---|
| code_info | Lot # 224TS; Exp. 02/17 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1039-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.